Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-

-

 
WKN: A2P2EX / Symbol: APVOV / Name: Aptevo Therapeutics / Stock / Biotechnology & Medical Research / Micro Cap /

Aptevo Therapeutics Inc. Stock

For the coming years our community has positive and negative things to say abot the Aptevo Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Innovation" there were negative voices in the community.

Unfortunately, there is no listed company called Aptevo Therapeutics with the symbol APVOV. However, there is a company with the symbol APVO. Aptevo Therapeutics is a biotechnology company that focuses on the discovery, development, and commercialization of novel oncology and hematology therapeutics. The company's product portfolio includes treatments for a variety of conditions such as hemophilia, immune disorders, and cancer. Their approach involves using genetically engineered proteins to target specific diseases and their therapies have shown promising results in clinical trials.

Pros and Cons of Aptevo Therapeutics Inc. in the next few years

Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Aptevo Therapeutics Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Aptevo Therapeutics Inc. - - - - - - -
Celsion Corp. 3.170% 0.000% -27.811% 2.521% 65.986% -91.743% -
India Globalization Capital -11.900% -2.116% 12.805% 35.036% 41.221% -71.003% -72.564%
CEL-SCI Corp. -0.450% -2.889% -25.932% -31.361% -49.186% -93.445% -

Comments

Buy Aptevo Therapeutics Inc.
Show more